ACYTE Biotech was incorporated to commercialise intellectual property arising from the mammalian cell research group at the University of New South Wales. ACYTE’s operations have been funded by contracts with major international pharma and biotech companies and support from the Australian Federal Government. ACYTE staff has expertise ranging from molecular biology through to cell culture and protein purification. The company has access to extensive facilities for growth of mammalian cells in containment laboratories up to the 130 litre scale and the subsequent purification of proteins produced as well as associated analytical equipment, and has access to the full range of genomics, proteomics, and metabolomics facilities.

ACYTE is run by a Board of Directors representing the shareholders. The current shareholders are the University of Queensland and Uniquest, University of NSW, New South Innovations Pty Ltd and the founders and inventors of the technology held by the company.